Angiographic and clinical outcome for the treatment of in-stent restenosis with sirolimus-eluting stent compared to vascular brachytherapy

Zeitschrift fur Kardiologie

Volumn 94, Issue 6, 2005, Pages 405-410

  Pohl, T ^a   Kupatt, C ^a   Steinbeck, G ^a   Boekstegers, P ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Drug eluting stent; In stent restenosis; Intravascular brachytherapy; Rapamycin

Indexed keywords

RAPAMYCIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BRACHYTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY STENT; DEATH; DRUG ELUTING STENT; DRUG IMPLANTATION; DRUG SAFETY; FEASIBILITY STUDY; FEMALE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; IN-STENT RESTENOSIS; INTERMETHOD COMPARISON; MALE; MORBIDITY; RECURRENT DISEASE; STATISTICAL SIGNIFICANCE; TIME SERIES ANALYSIS; TREATMENT OUTCOME;

AGE DISTRIBUTION; AGED; BLOOD VESSEL PROSTHESIS; BRACHYTHERAPY; CORONARY RESTENOSIS; DISEASE-FREE SURVIVAL; FEMALE; GERMANY; GRAFT OCCLUSION, VASCULAR; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; RISK ASSESSMENT; RISK FACTORS; SEX DISTRIBUTION; SIROLIMUS; STENTS; TREATMENT OUTCOME;

EID: 21544464769     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00392-005-0253-y     Document Type: Article

References (27)

1. Teirstein PS, Kuntz RE (2001) New frontiers in interventional cardiology: intravascular radiation to prevent restenosis. Circulation 104:2620-2626
2. Teirstein PS, King S (2003) Vascular radiation in a drug-eluting stent world: it's not over till it's over. Circulation 108:384-385
3. Waksman R (2002) Vascular brachytherapy: applications in the era of drug-eluting stents. Rev Cardiovasc Med 3(Suppl 5):S23-S30
4. Folkerts KH, Franz A, Kiefer A, Hennersdorf G (2002) Radiation exposure of health personnel and patients in the heart catheterization laboratory in during vascular brachytherapy. Z Kardiol 91(6):493-502
5. Silber S, von RP, Lossl P et al (2000) Safety and feasibility of intracoronary brachytherapy with the Novoste system within the scope of international multicenter studies. Z Kardiol 89(4):323-329
6. Saia F, Lemos PA, Sianos G et al (2003) Effectiveness of sirolimus-eluting stent implantation for recurrent in-stent restenosis after brachytherapy. Am J Cardiol 92:200-203
7. Schiele TM, Staber L, Kantlehner R et al (2002) Edge effect and late thrombosis - inevitable complications of vascular brachytherapy? Z Kardiol 91(11):869-878
8. Dietz R, Silber S, Baumgart D, Hehrlein C, Tebbe U (2001) Position paper on intracoronary brachytherapy. Z Kardiol 90(11):875-880
9. Sousa JE, Serruys PW, Costa MA (2003) New frontiers in cardiology: drug-eluting stents: Part II. Circulation 107:2383-2389
10. Sousa JE, Serruys PW, Costa MA (2003) New frontiers in cardiology: drug-eluting stents: Part I. Circulation 107:2274-2279
11. Grube E, Silber S, Hauptmann KE et al (2003) TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation 107(1):38-42
12. Morice MC, Serruys PW, Sousa JE et al (2002) A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346(23):1773-1780
13. Rensing BJ, Vos J, Smits PC et al (2001) Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasonic follow-up. Eur Heart J 22(22):2125-2130
14. Zahn R, Hamm CW, Zeymer U et al (2004) "Real life"; use of sirolimus-eluting coronary stents in Germany. Results from the prospective multicentre German Cypher Registry. Z Kardiol 93(4):287-294
15. Schofer J, Bode C, Silber S (2004) Drug-eluting stents for in-stent restenosis and acute myocardial infarction: present data from nonrandomized studies. Herz 29(2):195-200
16. Silber S (2002) Antiproliferative coated stents and intracoronary brachytherapy: common trails and differences. Z Kardiol 91(6):443-457
17. Degertekin M, Regar E, Tanabe K et al (2003) Sirolimus-eluting stent for treatment of complex in-stent restenosis: the first clinical experience. J Am Coll Cardiol 41(2):184-189
18. Tanabe K, Serruys PW, Grube E et al (2003) TAXUS III Trial: in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation. Circulation 107(4):559-564
19. Radke PW, Kobella S, Kaiser A et al (2004) Treatment of in-stent restenosis using a paclitaxel-eluting stent: acute results and long-term follow-up of a matched-pair comparison with intracoronary beta-radiation therapy. Eur Heart J 25(11):920-925
20. Mehran R, Dangas G, Abizaid AS et al (1999) Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 100(18):1872-1878
21. Waksman R, Bhargava B, White L et al (2000) Intracoronary beta-radiation therapy inhibits recurrence of in-stent restenosis. Circulation 101(16):1895-1898
22. Waksman R, Raizner AE, Yeung AC, Lansky AJ, Vandertie L (2002) Use of localised intracoronary beta radiation in treatment of in-stent restenosis: the INHIBIT randomised controlled trial. Lancet 359(9306):551-557
23. Holmes DR, Jr, Leon MB, Moses JW et al (2004) Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis. Circulation 109(5):634-640
24. Schofer J, Schluter M, Gershlick AH et al (2003) Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet 362(9390):1093-1099
25. McFadden EP, Stabile E, Regar E et al (2004) Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 364(9444):1519-1521
26. Naber CK, Kaiser CA, Rahman YA, Haude M, Erbel R, Baumgart D (2001) Late stent thrombosis after intracoronary brachytherapy. A case report and review of the literature. Z Kardiol 90(2):138-143
27. Lemos PA, van Miegem CAG, Arampatzis CA et al (2004) Post-Sirolimus- Eluting Stent Restenosis Treated With Repeat Percutaneous Intervention: Late Angiographic and Clinical Outcomes. Circulation 109(21):2500-2502